AMBIEN (zolpidem tartrate) is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. AMBIEN has been shown to … “Ultimately at Sanofi we felt that using our medicines as a crutch for bad behavior is unacceptable. We have diversity and inclusion as a core … Sustentabilidade Ambiental · Neutralidade de carbono até 2030 e zero emissões até 2045 · Limitar pegadas ambientais e adotar soluções circulares · Melhorar o … See full prescribing information for AMBIEN CR. AMBIEN CR® (zolpidem tartrate) extended-release tablets, for oral use, C-IV. Initial U.S. Approval: 1992. Cosette Pharmaceuticals Acquires Ambien® and Ambien CR® (Zolpidem Tartrate) Tabs from Sanofi US in the US Market · Seamless Transition Ensures Continued Supply … Zolpidem, sold under the brand name Ambien among others, is a medication primarily used for the short-term treatment of sleeping problems. Ambien (zolpidem tartrate) is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Ambien has been shown to … New Jersey-based Cosette Pharmaceuticals has acquired the insomnia medications Ambien and Ambien CR from Sanofi US.